JE-2147: a dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1.

@article{Yoshimura1999JE2147AD,
  title={JE-2147: a dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1.},
  author={K. Yoshimura and R. Kato and K. Yusa and M. Kavlick and V. Maroun and A. Nguyen and T. Mimoto and T. Ueno and M. Shintani and J. Falloon and H. Masur and H. Hayashi and J. Erickson and H. Mitsuya},
  journal={Proceedings of the National Academy of Sciences of the United States of America},
  year={1999},
  volume={96 15},
  pages={
          8675-80
        }
}
  • K. Yoshimura, R. Kato, +11 authors H. Mitsuya
  • Published 1999
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
We designed, synthesized, and identified JE-2147, an allophenylnorstatine-containing dipeptide HIV protease inhibitor (PI), which is potent against a wide spectrum of HIV-1, HIV-2, simian immunodeficiency virus, and various clinical HIV-1 strains in vitro. Drug-resistant clinical HIV-1 strains, isolated from seven patients who had failed 9-11 different anti-HIV therapeutics after 32-83 months, had a variety of drug-resistance-related amino acid substitutions and were highly and invariably… Expand
87 Citations
A Potent Human Immunodeficiency Virus Type 1 Protease Inhibitor, UIC-94003 (TMC-126), and Selection of a Novel (A28S) Mutation in the Protease Active Site
  • 120
  • PDF
Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteases
  • 32
Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease.
  • 32
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 21 REFERENCES
Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine.
  • 58
Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease.
  • 172
  • PDF
...
1
2
3
...